In a significant move to address rising healthcare costs, former President Trump has announced plans to sign an executive order that aims to cut prescription drug prices by up to 80%. The initiative seeks to align U.S. drug costs with those of other countries, ensuring that Americans pay no more than their international counterparts for medications. Trump has characterized this policy as a vital measure for Medicare and has urged drugmakers to adopt the same pricing structures used abroad. The announcement has been met with concerns from pharmaceutical companies and stakeholders in the healthcare sector, who fear potential revenue losses as a consequence of these sweeping changes.